PURPOSE: POAG is a complex disease; therefore, families in which a glaucoma gene has been mapped may carry additional POAG genes. The goal of this study was to determine whether mutations in the myocilin (MYOC) gene on chromosome 1 are present in two POAG families, which have previously been mapped to the GLC1C locus on chromosome 3. METHODS: The three exons of MYOC were screened by denaturing (d)HPLC. Samples with heteroduplex peaks were sequenced. Clinical findings were compared with genotype status in all available family members over the age of 20 years. RESULTS: A T377M coding sequence change in MYOC was identified in family members of the Greek GLC1C family but not in the Oregon GLC1C family. Individuals carrying both the MYOC T377M variant and the GLC1C haplotype were more severely affected at an earlier age than individuals with just one of the POAG genes, suggesting that these two genes interact or that both contribute to the POAG phenotype in a cumulative way.
PURPOSE: POAG is a complex disease; therefore, families in which a glaucoma gene has been mapped may carry additional POAG genes. The goal of this study was to determine whether mutations in the myocilin (MYOC) gene on chromosome 1 are present in two POAG families, which have previously been mapped to the GLC1C locus on chromosome 3. METHODS: The three exons of MYOC were screened by denaturing (d)HPLC. Samples with heteroduplex peaks were sequenced. Clinical findings were compared with genotype status in all available family members over the age of 20 years. RESULTS: A T377M coding sequence change in MYOC was identified in family members of the Greek GLC1C family but not in the Oregon GLC1C family. Individuals carrying both the MYOCT377M variant and the GLC1C haplotype were more severely affected at an earlier age than individuals with just one of the POAG genes, suggesting that these two genes interact or that both contribute to the POAG phenotype in a cumulative way.
Authors: George Kitsos; Zacharias Petrou; Maria Grigoriadou; John R Samples; Alex W Hewitt; Haris Kokotas; Aglaia Giannoulia-Karantana; David A Mackey; Mary K Wirtz; Marilita Moschou; John P A Ioannidis; Michael B Petersen Journal: Clin Ophthalmol Date: 2010-03-24
Authors: Molly M Walsh; Haiqing Yi; Julie Friedman; Kyoung-In Cho; Nomingerel Tserentsoodol; Stuart McKinnon; Kelly Searle; Andrew Yeh; Paulo A Ferreira Journal: Exp Biol Med (Maywood) Date: 2009-06-02
Authors: Alex W Hewitt; John R Samples; R Rand Allingham; Irma Järvelä; George Kitsos; Subbaiah R Krishnadas; Julia E Richards; Paul R Lichter; Michael B Petersen; Periasamy Sundaresan; Janey L Wiggs; David A Mackey; Mary K Wirtz Journal: Mol Vis Date: 2007-03-28 Impact factor: 2.367
Authors: Mary K Wirtz; John R Samples; Victoria Toumanidou; Jac Charlesworth; Dimitrios G Mikropoulos; Konstantinos Kaltsos; Athanasios Economou; Antonios Dimopoulos; Irene N Georgiadou; Georgios Moumtzis; Athanasios Papanastasiou; Patricia L Kramer; Tom Dyer; John Blangero; Anastasios G P Konstas Journal: Invest Ophthalmol Vis Sci Date: 2010-01-27 Impact factor: 4.799
Authors: Wenjing Liu; Yutao Liu; Pratap Challa; Leon W Herndon; Janey L Wiggs; Christopher A Girkin; R Rand Allingham; Michael A Hauser Journal: Mol Vis Date: 2012-08-10 Impact factor: 2.367
Authors: Li Jia Chen; Tsz Kin Ng; Alex H Fan; Dexter Y L Leung; Mingzhi Zhang; Ningli Wang; Yuqian Zheng; Xiao Ying Liang; Sylvia W Y Chiang; Pancy O S Tam; Chi Pui Pang Journal: Mol Vis Date: 2012-06-28 Impact factor: 2.367